2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Javier Rodríguez-Carrio, Agata Burska, Philip G. Conaghan, Willem A. Dik, Robert Biesen, Maija Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T. Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie Louise Frémond, Mary K. Crow, Lars Rönnblom, Marjan A. Versnel, Edward M. Vital

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of '2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds